PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July 30, 2025. On July 21, 2025, ZimVie issued a press release announcing ZimVie’s entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”) for $19.00 ...

Apollo Global Management is leading a £600 million private credit package for UK dental chain Mydentist https://t.co/GpzOavl36L ...

Strategic Partnership Provides Market Presence in Growing Chinese MarketPALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s global presence to further penetrate the ...

Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 OutlookCHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the “Board”), has been appointed President and Chief Executive Officer, ...

The Prototype: The Cool Tech Hiding In Your Dentist’s Officehttps://t.co/Zggj6HKJlQ https://t.co/SXGayJJmfa ...

Marketing & Advertising - A dental practitioner in LA used an AI-generated video of a gorilla getting dental work to create a viral ad [1] - The viral ad significantly increased bookings for the dental practice [1] - The success of the ad demonstrates that the quality of the idea matters more than its origin, even if it's AI-generated [1][2] - AI is democratizing ideas, making it a great time to be an ideas person [2] Consumer Perception - People generally don't care if content is AI-generated as long as it's good [2]

CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website ...

Core Viewpoint - Envista Holdings Corporation will report its financial results for the second quarter of 2025 on July 31, 2025, with a conference call scheduled for 2:00 PM PT to discuss these results [1]. Company Overview - Envista is a global family of over 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, focused on improving lives through dental care [4]. - The company offers a comprehensive portfolio that includes dental implants, orthodontics, and digital imaging technologies, addressing a wide range of clinical needs for dental professionals [4]. - Envista is recognized as one of the largest global dental products companies, holding significant market positions in attractive segments of the dental products industry [4]. Conference Call Details - The conference call will be accessible via a dial-in number, with a U.S. number of 1-800-836-8184 and an international number of +1 646-357-8785, starting a few minutes before the call [2]. - A replay of the webcast will be available shortly after the presentation concludes, and related materials will be posted on the "Investors" section of Envista's website [3].

Company Performance - McKesson's stock closed at $724.11, down 1.53% from the previous session, which is less than the S&P 500's loss of 0.07% [1] - Over the past month, McKesson's shares have appreciated by 3.83%, outperforming the Medical sector's loss of 1.3% and lagging behind the S&P 500's gain of 3.94% [1] Earnings Estimates - McKesson is expected to report earnings of $8.25 per share on August 6, 2025, reflecting a year-over-year growth of 4.7% [2] - The consensus estimate for revenue is projected at $96.08 billion, indicating a 21.18% increase compared to the same quarter of the previous year [2] Full-Year Projections - The full-year Zacks Consensus Estimates for McKesson are earnings of $37.25 per share and revenue of $405.91 billion, representing year-over-year changes of +12.71% and +13.05%, respectively [3] Analyst Sentiment - Recent changes to analyst estimates for McKesson indicate evolving short-term business trends, with positive revisions suggesting optimism about the business outlook [3][4] Zacks Rank - McKesson currently holds a Zacks Rank of 2 (Buy), with the Zacks Consensus EPS estimate shifting 0.16% upward over the past month [5] Valuation Metrics - McKesson's Forward P/E ratio is 19.74, which is a premium compared to the industry average Forward P/E of 18.21 [6] - The company has a PEG ratio of 1.47, while the Medical - Dental Supplies industry average PEG ratio is 1.67 [6] Industry Context - The Medical - Dental Supplies industry, part of the Medical sector, has a Zacks Industry Rank of 29, placing it in the top 12% of over 250 industries [7]

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is BioCryst Pharmaceuticals (BCRX) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.BioCryst Pharmaceuticals is a member of our Medical group, which includes 987 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best ...